Different response to rituximab in tumor necrosis factor blocker-naïve patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial - Commentary

Tom Huizinga; Peter Nigrovic; Eric Ruderman; Hendrik Schulze-Koops

Different response to rituximab in tumor necrosis factor blocker-naïve patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial - Commentary

Tom Huizinga^*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

^*Corresponding author for this work

Medicine, Rheumatology Division

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Number of pages	1
Journal	International Journal of Advances in Rheumatology
Volume	8
Issue number	3
State	Published - Dec 1 2010

ASJC Scopus subject areas

Rheumatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{1a1996081caa45149d8b337628541df9,

title = "Different response to rituximab in tumor necrosis factor blocker-na{\"i}ve patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial - Commentary",

author = "Tom Huizinga and Peter Nigrovic and Eric Ruderman and Hendrik Schulze-Koops",

year = "2010",

month = dec,

day = "1",

language = "English (US)",

volume = "8",

journal = "International Journal of Advances in Rheumatology",

issn = "1478-856X",

publisher = "Remedica Medical Education and Publishing Ltd",

number = "3",

}

Different response to rituximab in tumor necrosis factor blocker-naïve patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial - Commentary. / Huizinga, Tom; Nigrovic, Peter; Ruderman, Eric et al.
In: International Journal of Advances in Rheumatology, Vol. 8, No. 3, 01.12.2010.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Different response to rituximab in tumor necrosis factor blocker-naïve patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed

T2 - A twenty-four-week clinical trial - Commentary

AU - Huizinga, Tom

AU - Nigrovic, Peter

AU - Ruderman, Eric

AU - Schulze-Koops, Hendrik

PY - 2010/12/1

Y1 - 2010/12/1

UR - http://www.scopus.com/inward/record.url?scp=84863843357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863843357&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:84863843357

SN - 1478-856X

VL - 8

JO - International Journal of Advances in Rheumatology

JF - International Journal of Advances in Rheumatology

IS - 3

ER -

Different response to rituximab in tumor necrosis factor blocker-naïve patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial - Commentary

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this